Abstract
References
Articles referenced by this article (74)
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin, (3):209-249 2021
MED: 33538338
Macrophages and cancer: from mechanisms to therapeutic implications.
Trends Immunol, (4):229-239 2015
MED: 25770924
Understanding the tumor immune microenvironment (TIME) for effective therapy.
Nat Med, (5):541-550 2018
MED: 29686425
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization.
Cell, (2):313-326 2018
MED: 30290139
Introduction to checkpoint inhibitors and cancer immunotherapy.
Immunol Rev, (1):5-8 2017
MED: 28258698
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer.
Nat Rev Clin Oncol, (1):24-37 2013
MED: 24247168
Beyond immune checkpoint blockade: emerging immunological strategies.
Nat Rev Drug Discov, (12):899-919 2021
MED: 33686237
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging.
Cell, (6):1373-1387.e19 2018
MED: 30193111
Show 10 more references (10 of 74)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/158265209
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1038/s43018-023-00691-z
Article citations
Ultrasound-responsive nanocarriers with siRNA and Fe<sub>3</sub>O<sub>4</sub> regulate macrophage polarization and phagocytosis for augmented non-small cell lung cancer immunotherapy.
J Nanobiotechnology, 22(1):605, 07 Oct 2024
Cited by: 0 articles | PMID: 39375761 | PMCID: PMC11460142
Research progress of tumor-associated macrophages in immune checkpoint inhibitor tolerance in colorectal cancer.
World J Gastrointest Oncol, 16(10):4064-4079, 01 Oct 2024
Cited by: 0 articles | PMID: 39473964 | PMCID: PMC11514660
Review Free full text in Europe PMC
Targeting macrophages to reprogram the tumor immune microenvironment.
Blood Sci, 6(4):e00203, 15 Aug 2024
Cited by: 0 articles | PMID: 39149533 | PMCID: PMC11326473
Bio-inspired biorthogonal compartmental microparticles for tumor chemotherapy and photothermal therapy.
J Nanobiotechnology, 22(1):498, 20 Aug 2024
Cited by: 0 articles | PMID: 39164657 | PMCID: PMC11337894
SIRPα engagement regulates ILC2 effector function and alleviates airway hyperreactivity via modulating energy metabolism.
Cell Mol Immunol, 21(10):1158-1174, 19 Aug 2024
Cited by: 1 article | PMID: 39160226 | PMCID: PMC11442993
Go to all (9) article citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
J Hematol Oncol, 13(1):160, 30 Nov 2020
Cited by: 38 articles | PMID: 33256806 | PMCID: PMC7706287
Cancer immunotherapy targeting the CD47/SIRPα axis.
Eur J Cancer, 76:100-109, 10 Mar 2017
Cited by: 177 articles | PMID: 28286286
Review
The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
Immunol Rev, 276(1):145-164, 01 Mar 2017
Cited by: 260 articles | PMID: 28258703
Review
Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy.
Cell Commun Signal, 22(1):173, 11 Mar 2024
Cited by: 0 articles | PMID: 38462636 | PMCID: PMC10926604
Funding
Funders who supported this work.
National Natural Science Foundation of China (National Science Foundation of China) (4)
Grant ID: 82071745
Grant ID: 32370688
Grant ID: 32170646
Grant ID: 82150117
Shenzhen Science and Technology Innovation Commission (1)
Grant ID: JCYJ20220818100401003